ClinicalTrials.gg
RecruitingNCT05236803MOTRICITE TSAUpdated Mar 16, 2026

Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol

An interventional study of Testing of general motor skills, fine motor skills and occulomotricity and Questionnaires in Autism Spectrum Disorder, sponsored by Centre Hospitalier Charles Perrens, Bordeaux. Recruiting at 4 sites in France. Open to participants aged 6 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Centre Hospitalier Charles Perrens, Bordeaux · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Feb 2022; still recruiting 4 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Not applicable
Ages
6 Years to 11 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 110 studies in Autism Spectrum Disorder with a site in France — 51 open to participants now, 55 under way, 2 of them phase 3. Autism Spectrum Disorder · France.

Planned enrollment
28th of 77
110 · median 70
Started
2022
with 9 others
No phase
58 of 110
29 open now
Primary completion
2026-10
later than 15 of 54 live
Registered
58th of 110
by date

Among the 110 studies in Autism Spectrum Disorder with a site in France, this one is the 28th largest by planned enrollment of the 77 interventional ones that give a count, is one of 10 that started in 2022, is one of 58 with no phase, reaches primary completion later than 15 of the 54 other live ones, and was the 58th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

51 of the 110 studies in Autism Spectrum Disorder with a site in France are open now. Recruiting first, the newest first:

46 more — sign in →

All 51 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 6 Years to 11 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 110 studies in Autism Spectrum Disorder with a site in France, or all of them as a file.
02

Study summary

This research is a case-control study aiming to characterize motor peculiarities (objective quantitative and qualitative measures) and its psycho-physiological correlates of children with ASD.

Read the detailed description

The main objective is to measure jointly and in an automated and standardized manner the performance and motor patterns within the framework of tasks measuring the performance and patterns of general motor skills (postures, walking, coordination overall), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

The secondary objective is to investigate the relationships between motor difficulties and cognitive and social disorders found in children with ASD.

  • Compare the motor performance data in the 3 major motor domains with each other (overall, fine and oculomotor);
  • Evaluate intergroup differences based on clinical characteristics (ADOS-2, ADI-R, CARS 2 scores), age, IQ, socio-communication profile score (SRS-2) and presence comorbidities (TADH, TDC).
03

Conditions studied

  • Autism Spectrum Disorder

Keywords

  • Autisme Spectrum Disorders
  • Motricity
  • Cognitive disorders
  • Behaviour
  • motor skill differences
04

Who can participate

Ages eligible
6 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All participants :

  • Be between 6 and 11 years old
  • Mastery of the French language
  • Be affiliated with a Social Security scheme or benefit from affiliation by a third person
  • Both parents (or the holder of legal authority) have read, understood and signed the study consent
  • Be affiliated with social security

Participants with ASD should also verify the following inclusion criteria:

  • Being diagnosed with ASD ()

Exclusion criteria

Exclusion Criteria :

All participants :

  • Refusal to participate in the research on the part of the participant and / or holders of parental authority.
  • Be a person benefiting from enhanced protection, namely : persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment.
  • Have uncorrected visual or hearing problems
  • To have concomitant psychotropic drug treatments not stabilized, initiated in the last 2 months: antipsychotics, mood stabilizers, anti-epileptics, psychostimulants, antidepressants.
  • Have a motor handicap of the upper or lower limbs, fitted or not.
  • Have diagnosed neurological or psychiatric disorders, present a general or metabolic pathology having a known impact on the child's motor skills (eg: Epilepsy, Tics and Gilles de la Tourette Syndrome, Intellectual Deficiency, Neuromuscular Syndrome, Metabolic Neurological Syndrome , neoplasms)
  • Suspicion of low intellectual efficiency if at least one of the two subtests (Similarities or Matrices) of WISC V (retrieved from the medical file if the TSA participant) presents a result (standard score) strictly lower than 7.

Participants without ASD :

  • Participant with ADHD (Attention Deficit Disorder with or without Hyperactivity) or CDD (Developmental Coordination Disorder)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
110 participants (estimated)

Study arms

  • Other
    Epidemiology

    Recording of participant's performance during eye, fine motor and gross motor tests Passing self and hetero questionnaires.

    Behavioral: Testing of general motor skills, fine motor skills and occulomotricity · Behavioral: Questionnaires

Interventions

  • BehavioralTesting of general motor skills, fine motor skills and occulomotricity

    Recording of participant's performance during eye, fine motor and gross motor tests; Children's gross motor skills will be assessed through a biomechanical analysis. Eye movements will be recorded using the eye-tracking system (Tobii Pro TX300). The technique used is the corneal reflection technique.

  • BehavioralQuestionnaires

    Passing self and hetero questionnaires.

06

What researchers measure

Primary outcomes

  1. Measurement performance of fine motor skills (graphics, pointing task)

    Jointly and in an automated and standardized manner, measure performance in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Time frame: At 3 month

  2. Measurement performance of general motor skills with biomechanical analysis

    Jointly and in an automated and standardized manner, measure motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Time frame: At 3 month

  3. Measurement of oculomotricity with eye-tracking system (visual orientation and control)

    Jointly and in an automated and standardized manner, motor patterns in the context of tasks measuring the performance and patterns of general motor skills (postures, walking, overall coordination), fine motor skills (graphics, pointing task) and oculomotricity (visual orientation and control).

    Time frame: At 3 month

Secondary outcomes

  1. Motor performance : success, error rate (%)

    Time frame: At visit 1 and visit 2, an average of 3 months

  2. Motor performance : task duration (ms), reaction time (ms) and latency (ms)

    Time frame: At visit 1 and visit 2, an average of 3 months

  3. IQ as assessed using WISC IV

    Time frame: At visit 1 and visit 2, an average of 3 months

  4. Score of socio-communicative skills as assessed using Social Responsiveness Scale

    Social Responsiveness Scale : Min = 30, Max=90 Higher scores mean a worse outcome

    Time frame: At visit 1 and visit 2, an average of 3 months

  5. ADHD as assessed using Conners-3

    Time frame: At visit 1 and visit 2, an average of 3 months

  6. Developmental Coordination Disorder as assessed using Developmental Coordination Disorder Questionnaire

    Developmental Coordination Disorder Questionnaire : Min = 15, Max = 75 Higher scores mean a better outcome

    Time frame: At visit 1 and visit 2, an average of 3 months

  7. ASD Clinical Assessment as assessed using Childhood Autism Rating Scale

    Childhood Autism Rating Scale : Min = 0, Max = 100 Higher scores mean a worse outcome

    Time frame: At visit 1 and visit 2, an average of 3 months

07

Study locations

4 of 4 sites recruiting
08

References and documents

Publications

  • Biffi E, Costantini C, Ceccarelli SB, Cesareo A, Marzocchi GM, Nobile M, Molteni M, Crippa A. Gait Pattern and Motor Performance During Discrete Gait Perturbation in Children With Autism Spectrum Disorders. Front Psychol. 2018 Dec 11;9:2530. doi: 10.3389/fpsyg.2018.02530. eCollection 2018. PubMed 30618953 ↗
  • Cazalets JR, Bestaven E, Doat E, Baudier MP, Gallot C, Amestoy A, Bouvard M, Guillaud E, Guillain I, Grech E, Van-Gils J, Fergelot P, Fraisse S, Taupiac E, Arveiler B, Lacombe D. Evaluation of Motor Skills in Children with Rubinstein-Taybi Syndrome. J Autism Dev Disord. 2017 Nov;47(11):3321-3332. doi: 10.1007/s10803-017-3259-1. PubMed 28748333 ↗
  • D'Mello AM, Stoodley CJ. Cerebro-cerebellar circuits in autism spectrum disorder. Front Neurosci. 2015 Nov 5;9:408. doi: 10.3389/fnins.2015.00408. eCollection 2015. PubMed 26594140 ↗
  • Eggleston JD, Harry JR, Cereceres PA, Olivas AN, Chavez EA, Boyle JB, Dufek JS. Lesser magnitudes of lower extremity variability during terminal swing characterizes walking patterns in children with autism. Clin Biomech (Bristol). 2020 Jun;76:105031. doi: 10.1016/j.clinbiomech.2020.105031. Epub 2020 May 7. PubMed 32408186 ↗
  • Hak L, Houdijk H, Beek PJ, van Dieen JH. Steps to take to enhance gait stability: the effect of stride frequency, stride length, and walking speed on local dynamic stability and margins of stability. PLoS One. 2013 Dec 13;8(12):e82842. doi: 10.1371/journal.pone.0082842. eCollection 2013. PubMed 24349379 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Oct 2026, 56 months after the start.

Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 56 months is above that.

Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2021
First posted
Feb 11, 2022
StartActual
Feb 7, 2022
Primary completionEst.
Oct 30, 2026
CompletionEst.
Mar 31, 2027
Last update
Mar 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05236803
Lead sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Responsible party
Sponsor
First posted
Feb 11, 2022
Start date
Feb 7, 2022
Primary completion
Oct 30, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Mar 16, 2026

Study contacts

Anouck AMESTOY, MD
Contact
aamestoy@ch-perrens.fr
05 56 56 67 19
Helen SAVARIEAU
Contact
hsavarieau@ch-perrens.fr
05 56 56 35 56
Anouck AMESTOY, MD
study director · Physician

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion